retatrutide ruo | Research Peptide Retatrutide Peptide 10mg (RUO) |

In the obese trial cohort, 1 mg moved 24-hour ambulatory heart rate by +0.7 bpm at week 24 the peak of the heart-rate curve, and below the placebo arms +0.8. In a healthy lean Phase 1 group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population

Both semaglutide and tirzepatide slow gastric emptying as part of their mechanism

Antonie Van Leeuwenhoek

Others report more dramatic results, particularly patients using tirzepatide or those starting at higher body weights

Differences in glutathione synthesis and glutathione-S-transferase activities in hepatocytes from postnatal and adult mice

I occasionally have greens and superfood powders when I need a nutritional boost